Literature DB >> 28672405

Driving Performance of Depressed Patients who are Untreated or Receive Long-Term Antidepressant (SSRI/SNRI) Treatment.

Nick N J J M van der Sluiszen1, Marleen Wingen1, Annemiek Vermeeren1, Frederick Vinckenbosch1, Stefan Jongen1, Johannes G Ramaekers1.   

Abstract

Introduction Depression is a mental disorder likely to affect everyday functions. The present study aimed to assess actual driving performance of depressed patients who were without specific antidepressant treatment or received long-term antidepressant treatment. Methods A standardized on-the-road driving test was used to assess standard deviation of lateral position (SDLP) in 3 patient groups receiving either no antidepressant treatment (with or without benzodiazepine medication) or treatment with selective serotonin/noradrenalin reuptake inhibitors for a period of 6-52 weeks. Severity of depression was assessed using Beck's Depression Inventory and the Hamilton Depression Rating Scale. The performance of patient groups was compared to healthy controls. Results The mean SDLP of untreated and treated patients was significantly higher than that of healthy controls. Driving impairment in the long-term treated group was significantly less than in the untreated groups. SDLP was positively correlated to severity of depression across all groups. Discussion It is concluded that symptoms of depression are a major cause of driving impairment. Reductions in severity of depression through antidepressant treatment reduce severity of driving impairment. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28672405     DOI: 10.1055/s-0043-111600

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  6 in total

1.  Depressive and socially anxious symptoms, psychosocial maturity, and risk perception: Associations with risk-taking behaviour.

Authors:  Adam N Pailing; Renate L E P Reniers
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

2.  Driving with Tic Disorders: An International Survey of Lived Experiences.

Authors:  Lorena Fernández de la Cruz; Helene Ringberg; Seonaid Anderson; Jeremy S Stern; David Mataix-Cols
Journal:  Mov Disord Clin Pract       Date:  2021-03-10

3.  The Impact of Two MMPI-2-Based Models of Personality in Predicting Driving Behavior. Can Demographic Variables Be Disregarded?

Authors:  Luigi Tinella; Alessandro Oronzo Caffò; Antonella Lopez; Ignazio Grattagliano; Andrea Bosco
Journal:  Brain Sci       Date:  2021-03-02

4.  Driving performance and neurocognitive skills of long-term users of sedating antidepressants.

Authors:  Nick N J J M van der Sluiszen; Annemiek Vermeeren; Joke H van Dijken; Aurora J A E van de Loo; Janet L Veldstra; Dick de Waard; Joris C Verster; Karel A Brookhuis; Johannes G Ramaekers
Journal:  Hum Psychopharmacol       Date:  2020-10-01       Impact factor: 1.672

5.  An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users.

Authors:  Frederick R J Vinckenbosch; Annemiek Vermeeren; Eric F P M Vuurman; Nick N J J M van der Sluiszen; Joris C Verster; Aurora J A E van de Loo; Joke H van Dijken; Janet L Veldstra; Karel A Brookhuis; Dick De Waard; Johannes G Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-02-06       Impact factor: 1.672

6.  Driving Performance Under Treatment of Most Frequently Prescribed Drugs for Mental Disorders: A Systematic Review of Patient Studies.

Authors:  Alexander Brunnauer; Florian Herpich; Peter Zwanzger; Gerd Laux
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.